Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

समान संसाधन

• Supplementary Figure 2 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
  द्वारा: Dwight H. Owen (15034782)
  प्रकाशित: (2025)
• Supplementary Figure 3 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
  द्वारा: Dwight H. Owen (15034782)
  प्रकाशित: (2025)
• Supplementary Figure 4 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
  द्वारा: Dwight H. Owen (15034782)
  प्रकाशित: (2025)
• Supplementary Figure 5 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
  द्वारा: Dwight H. Owen (15034782)
  प्रकाशित: (2025)
• Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
  द्वारा: John A. Ligon (15024477)
  प्रकाशित: (2025)